ZEB1 and Neural Stem Cells: Insights into Microglia-Conditioned Medium-Driven Neuroinflammation

TL;DR

This study shows that reducing ZEB1 in neural stem cells decreases their activity and inflammation, suggesting ZEB1 could be a target for treating brain inflammation.

Contribution

The study reveals ZEB1 as a novel regulator of neural stem cell behavior in neuroinflammatory conditions.

Findings

ZEB1 knockdown reduced neurosphere formation and cell migration in neural stem cells.

ZEB1 silencing decreased reactive oxygen species and cytokine production in inflammatory conditions.

Targeting ZEB1 may offer a therapeutic strategy for neuroinflammatory disorders.

Abstract

What are the main findings?

ZEB1 knockdown in neural stem cells (NSCs) significantly reduced neurosphere formation, cell migration, reactive oxygen species generation, and cytokine produc-tion under both non-inflammatory conditions and inflammation induced by condi-tioned medium from LPS-activated microglia.

ZEB1 is a regulator of NSC behavior, modulating their responses to a neuroinflam-matory milieu.

What is the implication of the main finding?

Targeting ZEB1 may offer a novel therapeutic approach for controlling neuroinflam-mation and preserving neurogenesis in central nervous system disorders.

Modulation of ZEB1 could help protect NSC function during inflammatory challenges.

Neuroinflammation is a key response to disturbed CNS homeostasis, largely mediated by activated microglia, and excessive microglia-driven inflammation can negatively impact neurogenesis. ZEB1 plays a crucial role in neurogenesis and brain development by influencing neural stem cell (NSC) maintenance, proliferation, and differentiation. This study aimed to evaluate how the knockdown of ZEB1 influences the behavior of NSCs in inflammatory environments. NSCs were isolated from the subventricular zone of rats, and ZEB1 knockdown was achieved using ZEB1 siRNA. A conditioned medium derived from lipopolysaccharide-activated microglia was utilized to induce inflammatory responses in NSCs. The silencing of ZEB1 in NSCs significantly reduced the expression of ZEB1. Furthermore, ZEB1 knockdown in NSCs resulted in a significant decrease in neurosphere formation, cell migration ability, reactive oxygen species generation, and various cytokine levels under both non-inflammatory and inflammatory conditions. These findings reveal the regulatory role of ZEB1 in the modulation of NSC behavior, suggesting that targeting ZEB1 may provide a potential therapeutic strategy for neuroinflammatory CNS disorders.

Figures